Direct Biologics
Focus: Direct Biologics is an allograft-focused biotechnology company headquartered in Austin, TX, developing cell and exosome-based therapeutics across infectious diseases, immunology, respiratory, and ophthalmology indications.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Direct Biologics?
AI assessmentBest suited for early-stage biotech specialists seeking exposure to novel cell/exosome science with manageable near-term upside but limited near-term hiring and visibility.
Why Work Here
- Leading platform in exosome therapeutics with ExoFlo advancing to Phase 3 for ARDS, a serious unmet need with significant commercial potential
- Diversified pipeline spanning 11 active clinical programs across multiple high-value therapeutic areas (respiratory, GI, transplant, infectious disease)
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT05215288Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients
N/AHelp build intelligence for Direct Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.